Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo. [electronic resource]
Producer: 20180514Description: 1291-1299 p. digitalISSN:- 1791-2423
- Adenoviridae -- genetics
- Animals
- Antineoplastic Agents -- administration & dosage
- Apoptosis Regulatory Proteins -- genetics
- Carcinoma, Hepatocellular -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Combined Modality Therapy
- Drug Synergism
- Gene Expression Regulation, Neoplastic -- drug effects
- Genetic Vectors -- administration & dosage
- Hep G2 Cells
- Humans
- Liver Neoplasms -- genetics
- Mice
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Signal Transduction -- drug effects
- Tumor Suppressor Protein p53 -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.